HK Stock MarketDetailed Quotes

02315 BIOCYTOGEN-B

Watchlist
  • 6.080
  • +0.020+0.33%
Trading Sep 11 14:26 CST
2.43BMarket Cap-9088P/E (TTM)

BIOCYTOGEN-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
Turnover
25.60%410.5M
34.28%716.91M
42.64%326.84M
50.58%533.88M
--229.13M
39.84%354.56M
49.25%253.54M
--169.87M
Operating income
25.60%410.5M
34.28%716.91M
42.64%326.84M
50.58%533.88M
229.13M
39.84%354.56M
49.25%253.54M
169.87M
Cost of sales
-14.80%-105.01M
-48.37%-210.88M
-47.15%-91.47M
-32.69%-142.13M
---62.16M
-23.76%-107.12M
-18.99%-86.55M
---72.74M
Operating expenses
-14.80%-105.01M
-48.37%-210.88M
-47.15%-91.47M
-32.69%-142.13M
-62.16M
-23.76%-107.12M
-18.99%-86.55M
-72.74M
Gross profit
29.80%305.49M
29.17%506.03M
40.96%235.36M
58.32%391.75M
166.97M
48.17%247.44M
71.91%166.99M
97.14M
Selling expenses
-43.94%-42.47M
-25.04%-62.83M
-21.72%-29.51M
-19.55%-50.25M
---24.24M
-32.78%-42.03M
-8.89%-31.66M
---29.07M
Administrative expenses
12.69%-102.62M
-8.67%-286.26M
-9.21%-117.53M
-40.02%-263.41M
---107.63M
23.35%-188.12M
-75.12%-245.42M
---140.14M
Research and development expenses
34.80%-161.68M
32.15%-474.37M
24.36%-247.97M
-25.19%-699.17M
---327.82M
-102.13%-558.49M
-74.27%-276.31M
---158.55M
Revaluation surplus
588.22%6.48M
24.37%4.88M
-90.79%942K
-60.02%3.92M
--10.23M
-48.93%9.81M
1,221.48%19.21M
---1.71M
-Changes in the fair value of other assets
588.22%6.48M
24.37%4.88M
-90.79%942K
-60.02%3.92M
--10.23M
-48.93%9.81M
1,221.48%19.21M
---1.71M
Special items of operating profit
-54.54%9.53M
-51.26%42.26M
-45.39%20.96M
239.12%86.71M
--38.38M
192.28%25.57M
-21.27%8.75M
--11.11M
Operating profit
110.70%14.74M
49.05%-270.29M
43.57%-137.74M
-4.87%-530.44M
-244.1M
-41.12%-505.82M
-62.02%-358.43M
-221.22M
Financing cost
-13.00%-52.73M
-77.85%-99.84M
-145.50%-46.66M
-42.39%-56.14M
---19.01M
-74.93%-39.43M
-187.21%-22.54M
---7.85M
Share of profits of associates
-82.32%-9.09M
32.11%-10.03M
47.46%-4.98M
-3,574.13%-14.77M
---9.48M
-562.07%-402K
--87K
----
Special items of earning before tax
----
----
----
----
----
----
-23.89%-95.82M
---77.34M
Earning before tax
75.14%-47.08M
36.78%-380.16M
30.52%-189.39M
-10.21%-601.35M
-272.59M
-14.46%-545.64M
-55.57%-476.69M
-306.41M
Tax
-756.19%-3.6M
-247.76%-2.8M
---420K
---804K
----
----
----
----
After-tax profit from continuing operations
73.30%-50.67M
36.40%-382.95M
30.37%-189.81M
-10.36%-602.16M
-272.59M
-14.46%-545.64M
-55.57%-476.69M
-306.41M
Earning after tax
73.30%-50.67M
36.40%-382.95M
30.37%-189.81M
-10.36%-602.16M
-272.59M
-14.46%-545.64M
-55.57%-476.69M
-306.41M
Minority profit
----
99.53%-1K
99.52%-1K
-216.42%-212K
---208K
99.86%-67K
-12.59%-48.6M
---43.17M
Profit attributable to shareholders
73.30%-50.67M
36.38%-382.95M
30.32%-189.81M
-10.33%-601.95M
-272.39M
-27.44%-545.58M
-62.62%-428.09M
-263.24M
Basic earnings per share
72.92%-0.13
39.24%-0.96
34.25%-0.48
-4.64%-1.58
-0.73
10.12%-1.51
-23.53%-1.68
-1.36
Diluted earnings per share
72.92%-0.13
39.24%-0.96
34.25%-0.48
-4.64%-1.58
-0.73
10.12%-1.51
-23.53%-1.68
-1.36
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Auditor
--
KPMG
--
KPMG
--
KPMG
KPMG
KPMG
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019
Turnover 25.60%410.5M34.28%716.91M42.64%326.84M50.58%533.88M--229.13M39.84%354.56M49.25%253.54M--169.87M
Operating income 25.60%410.5M34.28%716.91M42.64%326.84M50.58%533.88M229.13M39.84%354.56M49.25%253.54M169.87M
Cost of sales -14.80%-105.01M-48.37%-210.88M-47.15%-91.47M-32.69%-142.13M---62.16M-23.76%-107.12M-18.99%-86.55M---72.74M
Operating expenses -14.80%-105.01M-48.37%-210.88M-47.15%-91.47M-32.69%-142.13M-62.16M-23.76%-107.12M-18.99%-86.55M-72.74M
Gross profit 29.80%305.49M29.17%506.03M40.96%235.36M58.32%391.75M166.97M48.17%247.44M71.91%166.99M97.14M
Selling expenses -43.94%-42.47M-25.04%-62.83M-21.72%-29.51M-19.55%-50.25M---24.24M-32.78%-42.03M-8.89%-31.66M---29.07M
Administrative expenses 12.69%-102.62M-8.67%-286.26M-9.21%-117.53M-40.02%-263.41M---107.63M23.35%-188.12M-75.12%-245.42M---140.14M
Research and development expenses 34.80%-161.68M32.15%-474.37M24.36%-247.97M-25.19%-699.17M---327.82M-102.13%-558.49M-74.27%-276.31M---158.55M
Revaluation surplus 588.22%6.48M24.37%4.88M-90.79%942K-60.02%3.92M--10.23M-48.93%9.81M1,221.48%19.21M---1.71M
-Changes in the fair value of other assets 588.22%6.48M24.37%4.88M-90.79%942K-60.02%3.92M--10.23M-48.93%9.81M1,221.48%19.21M---1.71M
Special items of operating profit -54.54%9.53M-51.26%42.26M-45.39%20.96M239.12%86.71M--38.38M192.28%25.57M-21.27%8.75M--11.11M
Operating profit 110.70%14.74M49.05%-270.29M43.57%-137.74M-4.87%-530.44M-244.1M-41.12%-505.82M-62.02%-358.43M-221.22M
Financing cost -13.00%-52.73M-77.85%-99.84M-145.50%-46.66M-42.39%-56.14M---19.01M-74.93%-39.43M-187.21%-22.54M---7.85M
Share of profits of associates -82.32%-9.09M32.11%-10.03M47.46%-4.98M-3,574.13%-14.77M---9.48M-562.07%-402K--87K----
Special items of earning before tax -------------------------23.89%-95.82M---77.34M
Earning before tax 75.14%-47.08M36.78%-380.16M30.52%-189.39M-10.21%-601.35M-272.59M-14.46%-545.64M-55.57%-476.69M-306.41M
Tax -756.19%-3.6M-247.76%-2.8M---420K---804K----------------
After-tax profit from continuing operations 73.30%-50.67M36.40%-382.95M30.37%-189.81M-10.36%-602.16M-272.59M-14.46%-545.64M-55.57%-476.69M-306.41M
Earning after tax 73.30%-50.67M36.40%-382.95M30.37%-189.81M-10.36%-602.16M-272.59M-14.46%-545.64M-55.57%-476.69M-306.41M
Minority profit ----99.53%-1K99.52%-1K-216.42%-212K---208K99.86%-67K-12.59%-48.6M---43.17M
Profit attributable to shareholders 73.30%-50.67M36.38%-382.95M30.32%-189.81M-10.33%-601.95M-272.39M-27.44%-545.58M-62.62%-428.09M-263.24M
Basic earnings per share 72.92%-0.1339.24%-0.9634.25%-0.48-4.64%-1.58-0.7310.12%-1.51-23.53%-1.68-1.36
Diluted earnings per share 72.92%-0.1339.24%-0.9634.25%-0.48-4.64%-1.58-0.7310.12%-1.51-23.53%-1.68-1.36
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified OpinionUnqualified OpinionUnqualified Opinion
Auditor --KPMG--KPMG--KPMGKPMGKPMG

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg